AtriCure reported a slight decrease in worldwide revenue for Q1 2020, with a more significant decrease in international revenue offsetting growth in the U.S. The company experienced a substantial increase in loss from operations and net loss per share compared to the same period in the previous year.
Worldwide revenue decreased by 1.4% year over year to $53.2 million.
U.S. revenue increased by 1.1% year over year to $43.5 million, driven by appendage management products.
International revenue decreased by 11.0% year over year to $9.8 million.
Net loss per share was $0.42, compared to $0.15 in the first quarter of 2019.
AtriCure has withdrawn its previously announced 2020 financial guidance that was issued on February 18, 2020, due to the continued uncertainties from the impact of COVID-19.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance